Image

The New Empowerment After eXposure to Trauma (NEXT) Study

The New Empowerment After eXposure to Trauma (NEXT) Study

Recruiting
18-50 years
Female
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The NEXT Study is a randomized controlled pilot examining the feasibility and acceptability of a revised perinatal PTSD protocol. This study will randomize perinatal participants with PTSD to receive NET (n=45); treatment group) and will be compared to perinatal women randomized to usual care (n=45; comparator group). The overall objective of this project is to determine the most feasible and acceptable protocol for a brief virtual perinatal PTSD intervention.

Eligibility

Inclusion Criteria:

  • 18 years of age or older
  • able to read and speak English
  • diagnosis of probable PTSD as determined by the PTSD Checklist for DSM-5 (PCL-5)
  • pregnant or postpartum (delivered within 16 weeks) at the time of the eligibility screen Exclusion criteria
  • current severe suicide risk
  • current psychotic or manic symptoms
  • cognitive impairment
  • concurrent trauma-focused psychotherapy
  • medical advice limiting participation in exposure therapy
  • current legal actions related to trauma
  • does not meet criteria for PTSD
  • not pregnant or delivered more than 17 weeks after timing of eligibility screening

Study details
    PTSD - Post Traumatic Stress Disorder
    PTSD (Childbirth-Related)

NCT07175025

Indiana University

1 November 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.